|
|
| | RGH-122 Basic information |
| Product Name: | RGH-122 | | Synonyms: | RGH-122;Spiro[1,3-dioxolane-2,5′(6′H)-[4H][1,2,4]triazolo[4,3-a][1]benzazepine], 8′-chloro-1′-[trans-4-(2-pyridinyloxy)cyclohexyl]- | | CAS: | 2355304-05-9 | | MF: | C24H25ClN4O3 | | MW: | 452.93 | | EINECS: | | | Product Categories: | | | Mol File: | 2355304-05-9.mol |  |
| | RGH-122 Chemical Properties |
| Boiling point | 663.801±65.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.477±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 3.519±0.10(predicted) |
| | RGH-122 Usage And Synthesis |
| Uses | RGH-122 (compound 43) is an orally active, potent, selective, and hV1a receptor antagonist with Ki value of 0.3 nM and IC50 of 0.9 nM. RGH-122 showes microsomal stability with CLint value of 13/28/25 μL/min/mg[1]. | | References | [1] Baska F, et al. Discovery and Characterization of RGH-122, a Potent, Selective, and Orally Bioavailable V1a Receptor Antagonist. J Med Chem. 2024 Jan 11;67(1):643-673. DOI:10.1021/acs.jmedchem.3c01868 |
| | RGH-122 Preparation Products And Raw materials |
|